Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinoma

1 Jan 2023

Abstract excerpt

N6-methyladenosine methylation (m6A) is a common type of epigenetic alteration that prominently affects the prognosis of tumor patients. However, it is unknown how the m6A regulator affects the tumor microenvironment (TME) cell infiltration in adrenocortical carcinoma (ACC) and how it affects the prognosis of ACC patients yet. The m6A alteration patterns of 112 ACC patients were evaluated, furthermore, the...

Topics

Join the communities discussing this publication.

Epigenetics and DNA Methylation
Ferroptosis and cancer prognosis
RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37547754
DOI: 10.32604/or.2023.029414

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinomaPMID 37547754Read ↗

Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.Semantic proximity Read ↗

Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinomaSemantic proximity Read ↗

Comprehensive Characterization of m6A Regulators-Mediated Methylation Modification Patterns and Tumor Microenvironment Signature in Breast CancerSemantic proximity Read ↗

Molecular characterization and prognostic relevance of m6A regulators in pancreatic adenocarcinomaSemantic proximity Read ↗

m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic CancerSemantic proximity Read ↗

A four-m6A methylation regulator risk score was an independent prognostic biomarker for adrenocortical carcinomaSemantic proximity Read ↗

Characterization of m6A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma.Semantic proximity Read ↗

Characteristic of Classification and Prognostic Scoring Based on M6a RNA Methylation Modification in Lung Adenocarcinoma and Tumor Microenvironment AssociationSemantic proximity Read ↗

m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer MicroenvironmentSemantic proximity Read ↗

M6a Regulator-Associated Methylation Modification Patterns Shape Tumor Microenvironment Characteristics in Hepatocellular CarcinomaSemantic proximity Read ↗

m6A RNA Methylation Regulators de fine tumor microenvironment and predict prognosis in hepatocellular carcinomaSemantic proximity Read ↗

The Characteristics of Tumor Microenvironment Predict Survival and Response to Immunotherapy in Adrenocortical CarcinomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.